301 related articles for article (PubMed ID: 26763377)
21. Simultaneous Single-Particle Tracking and Dynamic pH Sensing Reveal Lysosome-Targetable Mesoporous Silica Nanoparticle Pathways.
Zhang RL; Pratiwi FW; Chen BC; Chen P; Wu SH; Mou CY
ACS Appl Mater Interfaces; 2020 Sep; 12(38):42472-42484. PubMed ID: 32657564
[TBL] [Abstract][Full Text] [Related]
22. Efficient photoacoustic imaging using indocyanine green (ICG) loaded functionalized mesoporous silica nanoparticles.
Chaudhary Z; Khan GM; Abeer MM; Pujara N; Wan-Chi Tse B; McGuckin MA; Popat A; Kumeria T
Biomater Sci; 2019 Nov; 7(12):5002-5015. PubMed ID: 31617526
[TBL] [Abstract][Full Text] [Related]
23. Hybrid silica-coated Gd-Zn-Cu-In-S/ZnS bimodal quantum dots as an epithelial cell adhesion molecule targeted drug delivery and imaging system.
Akbarzadeh M; Babaei M; Abnous K; Taghdisi SM; Peivandi MT; Ramezani M; Alibolandi M
Int J Pharm; 2019 Oct; 570():118645. PubMed ID: 31465835
[TBL] [Abstract][Full Text] [Related]
24. Mesoporous Silica Nanoparticle-Coated Microneedle Arrays for Intradermal Antigen Delivery.
Tu J; Du G; Reza Nejadnik M; Mönkäre J; van der Maaden K; Bomans PHH; Sommerdijk NAJM; Slütter B; Jiskoot W; Bouwstra JA; Kros A
Pharm Res; 2017 Aug; 34(8):1693-1706. PubMed ID: 28536970
[TBL] [Abstract][Full Text] [Related]
25. Chitosan-capped mesoporous silica nanoparticles as pH-responsive nanocarriers for controlled drug release.
Hu X; Wang Y; Peng B
Chem Asian J; 2014 Jan; 9(1):319-27. PubMed ID: 24115568
[TBL] [Abstract][Full Text] [Related]
26. Theranostic nanoparticles enabling the release of phosphorylated gemcitabine for advanced pancreatic cancer therapy.
Wang Q; Zhu X; Wu Z; Sun T; Huang W; Wang Z; Ding X; Jiang C; Li F
J Mater Chem B; 2020 Mar; 8(12):2410-2417. PubMed ID: 32100811
[TBL] [Abstract][Full Text] [Related]
27. Protein-gold clusters-capped mesoporous silica nanoparticles for high drug loading, autonomous gemcitabine/doxorubicin co-delivery, and in-vivo tumor imaging.
Croissant JG; Zhang D; Alsaiari S; Lu J; Deng L; Tamanoi F; AlMalik AM; Zink JI; Khashab NM
J Control Release; 2016 May; 229():183-191. PubMed ID: 27016140
[TBL] [Abstract][Full Text] [Related]
28. Synergetic gating of metal-latching ligands and metal-chelating proteins for mesoporous silica nanovehicles to enhance delivery efficiency.
Wu S; Deng Q; Huang X; Du X
ACS Appl Mater Interfaces; 2014 Sep; 6(17):15217-23. PubMed ID: 25137673
[TBL] [Abstract][Full Text] [Related]
29. Biodegradable, pH-Sensitive Hollow Mesoporous Organosilica Nanoparticle (HMON) with Controlled Release of Pirfenidone and Ultrasound-Target-Microbubble-Destruction (UTMD) for Pancreatic Cancer Treatment.
Gao F; Wu J; Niu S; Sun T; Li F; Bai Y; Jin L; Lin L; Shi Q; Zhu LM; Du L
Theranostics; 2019; 9(20):6002-6018. PubMed ID: 31534533
[TBL] [Abstract][Full Text] [Related]
30. Multistage pH-responsive mesoporous silica nanohybrids with charge reversal and intracellular release for efficient anticancer drug delivery.
Yuan X; Peng S; Lin W; Wang J; Zhang L
J Colloid Interface Sci; 2019 Nov; 555():82-93. PubMed ID: 31377647
[TBL] [Abstract][Full Text] [Related]
31. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
Bauer TW; Liu W; Fan F; Camp ER; Yang A; Somcio RJ; Bucana CD; Callahan J; Parry GC; Evans DB; Boyd DD; Mazar AP; Ellis LM
Cancer Res; 2005 Sep; 65(17):7775-81. PubMed ID: 16140945
[TBL] [Abstract][Full Text] [Related]
32. Unsaturated nitrogen-rich polymer poly(l-histidine) gated reversibly switchable mesoporous silica nanoparticles using "graft to" strategy for drug controlled release.
Mu S; Liu Y; Wang T; Zhang J; Jiang D; Yu X; Zhang N
Acta Biomater; 2017 Nov; 63():150-162. PubMed ID: 28873341
[TBL] [Abstract][Full Text] [Related]
33. Controlled release of silyl ether camptothecin from thiol-ene click chemistry-functionalized mesoporous silica nanoparticles.
Yan Y; Fu J; Wang T; Lu X
Acta Biomater; 2017 Mar; 51():471-478. PubMed ID: 28131940
[TBL] [Abstract][Full Text] [Related]
34. Hydrophobic binding peptide-conjugated hybrid lipid-mesoporous silica nanoparticles for effective chemo-photothermal therapy of pancreatic cancer.
Thapa RK; Nguyen HT; Gautam M; Shrestha A; Lee ES; Ku SK; Choi HG; Yong CS; Kim JO
Drug Deliv; 2017 Nov; 24(1):1690-1702. PubMed ID: 29098877
[TBL] [Abstract][Full Text] [Related]
35. Hyaluronic acid-capped compact silica-supported mesoporous titania nanoparticles for ligand-directed delivery of doxorubicin.
Gupta B; Poudel BK; Ruttala HB; Regmi S; Pathak S; Gautam M; Jin SG; Jeong JH; Choi HG; Ku SK; Yong CS; Kim JO
Acta Biomater; 2018 Oct; 80():364-377. PubMed ID: 30201431
[TBL] [Abstract][Full Text] [Related]
36. Advances in Functionalized Mesoporous Silica Nanoparticles for Tumor Targeted Drug Delivery and Theranostics.
Zhang W; Liu M; Liu A; Zhai G
Curr Pharm Des; 2017; 23(23):3367-3382. PubMed ID: 27784244
[TBL] [Abstract][Full Text] [Related]
37. Targeted anticancer potential against glioma cells of thymoquinone delivered by mesoporous silica core-shell nanoformulations with pH-dependent release.
Shahein SA; Aboul-Enein AM; Higazy IM; Abou-Elella F; Lojkowski W; Ahmed ER; Mousa SA; AbouAitah K
Int J Nanomedicine; 2019; 14():5503-5526. PubMed ID: 31410001
[TBL] [Abstract][Full Text] [Related]
38. Dual-Modality Surface-Enhanced Resonance Raman Scattering and Multispectral Optoacoustic Tomography Nanoparticle Approach for Brain Tumor Delineation.
Neuschmelting V; Harmsen S; Beziere N; Lockau H; Hsu HT; Huang R; Razansky D; Ntziachristos V; Kircher MF
Small; 2018 Jun; 14(23):e1800740. PubMed ID: 29726109
[TBL] [Abstract][Full Text] [Related]
39. Sterically Stabilised Polymeric Mesoporous Silica Nanoparticles Improve Doxorubicin Efficiency: Tailored Cancer Therapy.
Moodley T; Singh M
Molecules; 2020 Feb; 25(3):. PubMed ID: 32046364
[TBL] [Abstract][Full Text] [Related]
40. Facile Synthesis of Chitosan Capped Mesoporous Silica Nanoparticles: A pH Responsive Smart Delivery Platform for Raloxifene Hydrochloride.
Shah PV; Rajput SJ
AAPS PharmSciTech; 2018 Apr; 19(3):1344-1357. PubMed ID: 29340980
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
